The plasminogen–activator plasmin system in physiological and pathophysiological angiogenesis

AA Ismail, BT Shaker, K Bajou - International Journal of Molecular …, 2021 - mdpi.com
Angiogenesis is a process associated with the migration and proliferation of endothelial
cells (EC) to form new blood vessels. It is involved in various physiological and …

The urokinase‐type plasminogen activator system in cancer metastasis: a review

PA Andreasen, L Kjøller, L Christensen… - … journal of cancer, 1997 - Wiley Online Library
The urokinase‐type plasminogen activator (u‐PA) system consists of the serine proteinases
plasmin and u‐PA; the serpin inhibitors α2‐anti‐plasmin, PAI‐1 and PAI‐2; and the u‐PA …

The plasminogen activation system in tumor growth, invasion, and metastasis

PA Andreasen*, R Egelund, HH Petersen - Cellular and Molecular Life …, 2000 - Springer
Generation of the serine proteinase plasmin from the extracellular zymogen plasminogen
can be catalyzed by either of two other serine proteinases, the urokinase-and tissue-type …

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding

MH Kubala, YA DeClerck - Cancer and Metastasis Reviews, 2019 - Springer
The paradoxical pro-tumorigenic function of plasminogen activator inhibitor 1 (PAI-1, aka
Serpin E1) in cancer progression and metastasis has been the subject of an abundant …

Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing

VR Placencio, YA DeClerck - Cancer research, 2015 - AACR
Despite its function as an inhibitor of urokinase and tissue-type plasminogen activator (PA),
PA inhibitor-1 (PAI-1) has a paradoxical protumorigenic role in cancer, promoting …

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

HA Chapman - Current opinion in cell biology, 1997 - Elsevier
Cellular migration is critically dependent on an interplay between forces of attachment and
detachment. Recent studies show that the serine protease urokinase and its major inhibitor …

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

GA McMahon, E Petitclerc, S Stefansson… - Journal of Biological …, 2001 - ASBMB
Elevated expression of plasminogen activator inhibitor-1 (PAI-1) in tumors is associated with
a poor prognosis in many cancers. Reduced tumor growth and angiogenesis have also …

The pro‐or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

L Devy, S Blacher, C Grignet-Debrus… - The FASEB …, 2002 - Wiley Online Library
ABSTRACT Plasminogen activator inhibitor 1 (PAI‐1) is believed to control proteolytic
activity and cell migration during angiogenesis. We previously demonstrated in vivo that this …

PAI‐1, progress in understanding the clinical problem and its aetiology

T Iwaki, T Urano, K Umemura - British journal of haematology, 2012 - Wiley Online Library
Summary Plasminogen activator inhibitor‐1 (PAI‐1, also known as SERPINE 1) is a member
of the serine protease inhibitor (SERPIN) superfamily and is the primary physiological …

Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1

LS Gutierrez, A Schulman, T Brito-Robinson, F Noria… - Cancer research, 2000 - AACR
In vivo tumor progression in mice with targeted deficiencies in urokinase-type plasminogen
activator (UPA−/−) and its inhibitor, plasminogen activator inhibitor-1 (PAI-1−/−), was studied …